Atossa Genetics Net Income

As reflected in current metrics, Atossa Genetics posts the short-cycle RSI reading of 38, reflecting mild downside bias. Momentum in this band leans bearish but lacks the intensity that typically precedes a sharp move lower.Current projections place Total Revenue at 0.00, representing a change of NaN%. Last year, Atossa Genetics recorded Total Revenue of 0.00. As of this month (March), Gross Profit is expected to decrease toward approximately -16.1 K. In addition to that, Pretax Profit Margin is projected to grow to -7,929

Atossa Genetics Total Revenue

0.0

Examining Atossa Genetics's income statement, balance sheet, and cash flow together gives a multi-dimensional view of its financial health and valuation potential. Key drivers are highlighted below:Over one hundred nineteen fundamental trends are available for Atossa Genetics, supporting both time-series and peer-group analysis. A careful review of Atossa Genetics' regular performance relative to the period from 2010 to 2026 can reveal whether underlying fundamentals are strengthening or weakening. As of this month (March), Market Cap is projected to grow to approximately 112.3 M. Also, Enterprise Value is projected to grow to approximately 45.1 M Equity Screeners complement this analysis by enabling custom filters across sectors and regions.

		Last Reported	Projected for Next Year
	Net Loss	-23 M	-21.8 M
	Net Loss	-23 M	-24.1 M
	Net Loss	-24.3 M	-25.5 M
	Net Loss	-2.74	-2.87
	Net Income Per E B T	1.11	0.92

As of this month (March), Net Loss is projected to grow to approximately -21.8 M. In addition to that, Net Loss is expected to decrease toward approximately -24.1 M.